ReviewJournal of echocardiography2026
Echocardiographic imaging for transcatheter edge-to-edge repair: evaluation, guidance, and follow-up.
Review in Journal of echocardiography, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transcatheter edge-to-edge repair (TEER) requires precise echocardiographic guidance because the operator cannot directly visualize the mitral valve. Intraprocedural transesophageal echocardiography (TEE) is indispensable for safe and accurate device positioning and manipulation, whereas transthoracic echocardiography (TTE) plays a central role in preprocedural evaluation and serial postprocedural follow-up as part of comprehensive echocardiographic assessment. Before the procedure, echocardiography is essential for assessing the underlying mechanism and severity of mitral regurgitation (MR), determining anatomical suitability for TEER, and estimating procedural difficulty. Measurements such as mitral valve area, transmitral pressure gradient, tethering height, coaptation length, prolapse width and gap, as well as lesion location, leaflet morphology, and calcification distribution are crucial for predicting feasibility and technical complexity. During TEER, TEE must rapidly provide optimal views to guide each procedural step-from transseptal puncture to leaflet grasping and device deployment. Although X-plane imaging and three-dimensional reconstruction are now standard in many centers, live multiplanar reconstruction allows optimal imaging planes to be reconstructed in real time from acoustically favorable probe positions chosen to minimize device-related shadowing, thereby facilitating accurate and efficient intraprocedural guidance. Intraprocedural TEE is also vital for the early detection of complications, including pericardial effusion, leaflet injury, and clinically significant iatrogenic atrial septal defect with right-to-left shunting, as well as for immediate post-deployment hemodynamic assessment. In the postprocedural period, TTE focuses on detection of residual MR, evaluation for iatrogenic mitral stenosis, identification of single-leaflet device attachment or leaflet perforation, and serial assessment of cardiac function. Recent risk scores for patient selection and prognostication underscore the importance of comprehensive, evidence-informed echocardiographic evaluation that integrates both morphological and hemodynamic information.
Indexed as
Identifiers
42525232What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.